Healthcare ❯Pharmaceuticals ❯Drug Development ❯Weight Loss Drugs

Zepbound

Eli Lilly Reports Mixed Q4 Results as Key Drug Sales Fall Short of Expectations

Eli Lilly Shares Plunge After Disappointing Q3 Earnings and Sales